/PRNewswire/ Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma and medical partners, proudly announces the.
Better Therapeutics (BTTX) and Glooko Partner to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the US streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Glooko, Inc., a global leader in chronic condition management, specializing in connected care and remote patient monitoring for diabetes and.
Glooko will integrate Hedia's technology into its diabetes management platform. It expects to launch in Europe in the fourth quarter this year and the first quarter in 2024.